LAUREN KAUFFMAN: Open Payments
NPI 1558032243 · ONTARIO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$374 in 22 payments from 8 companies in 2025. Trend: 2023 $101 · 2024 $641 · 2025 $374
Food & beverage: $374
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $138 |
| Lilly USA, LLC | 4 | $60 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Amgen Inc. | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Novo Nordisk Inc | 2 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: BREZTRI, MOUNJARO, AIRSUPRA, OTEZLA, VOQUEZNA, Ozempic, SHINGRIX, FARXIGA.
Industry payments across OH — which companies pay providers there.
